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ABSTRACT
This study evaluated the capacity of 23 multidrug-resistant (MDR) clinical isolates of Acinetobacter
baumannii to adhere to respiratory epithelial cell surfaces and to form biofilm on a polystyrene surface.
All 23 A. baumannii isolates were capable of adhering efficiently to respiratory epithelial cells, and
biofilm production was positively associated with epithelial cell adhesiveness (r 0.80, p <0.0001). In the
presence of the chelating agent EDTA, biofilm formation was markedly reduced. Cell adhesiveness and
biofilm formation were significantly higher in isolates carrying the blaPER-1 gene as compared with
isolates without this extended-spectrum b-lactamase gene (p <0.005 and p <0.001, respectively). Further
examination by RT-PCR showed a positive correlation between the level of expression of the blaPER-1
gene and the level of biofilm formation (r 0.89, p <0.0001) and cell adhesiveness (r 0.74, p <0.006).
Overall, the study demonstrated a high capacity of clinical isolates of MDR A. baumannii to form biofilm
and to adhere to respiratory epithelial cells. This feature, combined with multidrug resistance, might
contribute to the survival of these organisms and their dissemination in the hospital environment.
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INTRODUCTION
Acinetobacter baumannii is an important nosoco-
mial pathogen that causes a range of infections,
including respiratory and urinary tract infections,
meningitis, endocarditis, wound infections and
bacteraemia, especially in intensive care unit
patients [1–3]. In the past, these organisms were
frequently ignored when isolated from clinical
samples, but significant improvements in resus-
citation techniques have changed the types of
infection caused by Acinetobacter, which is now a
serious problem among patients in intensive care
units [1–3]. In addition, interest in A. baumannii
has been growing rapidly because of the emer-
gence of multidrug-resistant (MDR) strains of this
species, some of which are pan-resistant to anti-
microbial agents [4–7].
MDR strains of A. baumannii are notorious
for their ability to spread among hospitalised
patients, and outbreaks caused by particular
strains of A. baumannii have been reported with
increasing frequency worldwide [4,5,7–11]. Risk-
factors identified for the isolation of MDR A. bau-
mannii include the severity of a patient’s condi-
tion, the use of invasive devices, and the use of
broad-spectrum antibiotics, all of which promote
MDR A. baumannii colonisation, growth and inva-
siveness [1,3,12]. However, the ability of MDR
A. baumannii strains to disseminate widely seems
to depend on the expression of virulence factors
that enable bacterial colonisation as well as on the
expression of antibiotic resistance.
Adherence of bacteria to epithelial cells is
considered to be an essential first step in coloni-
sation and subsequent infection of a host [13]. In
addition, biofilm formation is thought to be an
important pathogenic feature, especially in
relation to intravascular line infections and
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ventilator-associated pneumonia. Biofilm is a
microbially derived sessile community which
is characterised by cells that are irreversibly
attached to a substratum or interface with each
other, and that are embedded in a matrix of self-
produced extracellular polymeric substances [14].
Organisms that cause many device-related and
other chronic infections grow in biofilms in or on
these devices, and such infections are extremely
difficult to eradicate because of the resistance of
biofilm to numerous antimicrobial agents and
products of the immune system [14,15].
The present study used a bacterial adhesion
assay and a biofilm formation assay to investigate
the capacity of MDR clinical isolates of A. bauman-
nii to adhere to respiratory epithelial cell surfaces
and to form biofilm on a polystyrene surface.
These properties were compared in isolates with
and without the blaPER-1 gene, which encodes the
PER-1 extended-spectrum b-lactamase and is
prevalent among cefepime-resistant A baumannii
[7,8,10,16]. In addition, the study investigated
whether the biofilms formed could be inhibited
by a chelating agent, i.e., EDTA, which has the
ability to bind cations that may be required to




Twenty-three clinical isolates of A. baumannii (12 isolates
carrying the blaPER-1 gene and 11 isolates without blaPER-1)
were selected from among 40 MDR clinical isolates of
A. baumannii that had been characterised previously in terms
of their antimicrobial susceptibility, antimicrobial resistance
genes and genotype [16]. These isolates were originally
recovered from patients hospitalised in a university hospital
in Korea between August 2004 and March 2005. The type
strain of A. baumannii (ATCC 19606) was used for comparisons
in cell adhesion and biofilm assays. Escherichia coli strain
HB101 was used as a negative control in biofilm assays.
Bacterial adherence assay
Cells of the human bronchial epithelial cell line NCI-H292
(ATCC CRL-1848; American Tissue Culture Collection, Rock-
ville, MD, USA) were cultured at 37C in RPMI 1640 medium
(Gibco BRL, Grand Island, NY, USA), supplemented with
25 mM HEPES, 2 mM L-glutamine, penicillin G 100 000 U ⁄L,
streptomycin 50 mg ⁄L and fetal bovine serum (Gibco BRL)
10% v ⁄v, in a humidified atmosphere containing CO2 5% v ⁄v.
NCI-H292 cells were prepared by seeding 2 · 105 cells on
13-mm-diameter plastic coverslips (Thermanox; Nunc, Roches-
ter, NY, USA), which were then placed in four-well plates
containing RPMI 1640 medium. The cells were incubated at
37C for 16–24 h and were then washed with phosphate-
buffered saline (PBS). Bacteria grown on blood agar plates at
35C were suspended in RPMI 1640 medium at a density of
c. 4 · 107 CFU ⁄ 0.5 mL. Each cell monolayer was infected with
0.5 mL of bacterial suspension and incubated for 60 min at
37C in a CO2 5% v ⁄v atmosphere. The non-adherent bacteria
were then removed by washing three times with PBS. The
bacteria that had adhered to NCI-H292 cells were fixed in
methanol 100% for 20 min and stained for 30 min in a Giemsa
staining solution. The coverslips were air-dried, mounted and
viewed under a light microscope at a magnification of ·400.
The number of bacteria adhering to 100 cells was determined.
Three independent experiments were performed for each
isolate.
Adherence to polystyrene surface and measurement of
biofilm
Bacterial adherence to polystyrene was determined essentially
as described by Rosenberg [17]. A polystyrene disk was
pressed on the surface of a blood agar plate on which spots of
bacterial isolates had been grown at 37C for 24 h. The
polystyrene disk was then washed extensively with tap water
and stained with gentian violet. E. coli strain HB101 was used
as a negative control.
The relative amount of biofilm formed by the A. baumannii
isolates was measured using a biofilm formation assay in
microtitre plates, based on procedures outlined by Heilman
et al. [18]. In brief, overnight cultures were adjusted to an
OD600 of 2.0 and diluted 200-fold in Luria–Bertoni medium.
Aliquots (200 lL) of bacterial suspension were then inoculated
into each well of a 96-well flat-bottomed polystyrene plate and
incubated overnight at 37C. The wells were then washed
twice with 200 lL of PBS, air-dried, and stained with gentian
violet 0.1% v ⁄v for 15 min. The stained biofilms were then
solubilised with ethanol 95% v ⁄v for 5 min, and the biofilm
cell-associated dye was measured at OD570 using an ELISA
reader (VERSA max, Sunnyvale, CA, USA). Each experiment
was performed in triplicate and repeated three times.
Inhibition of biofilm formation by EDTA
The inhibitory effect of EDTA on biofilm formation was
evaluated using A. baumannii isolate 1656-2, which formed the
highest amount of biofilm (see Results). A 200-lL aliquot of
A. baumannii suspension was inoculated into each well of a
flat-bottomed 96-well polystyrene plate and was incubated
overnight at 37C in the presence or absence of EDTA
125 mg ⁄L, after which the amount of biofilm produced was
measured as described above.
Scanning electron-microscopy
An A. baumannii suspension (500 lL) was inoculated into
each well (containing a plastic coverslip) of four-well
polystyrene plates and then incubated overnight at 37C,
with or without EDTA treatment (125 mg ⁄L). Biofilms that
formed on the plastic coverslips were then washed twice
with 1 mL of PBS and fixed with paraformaldehyde 4% v ⁄v
in 0.1 M phosphate buffer (pH 7.4) for 30 min. The biofilms
on the coverslips were sequentially dehydrated for 5 min in
ethanol 50%, 70%, 90% and 100% v ⁄v, and then fixed to
aluminium stubs using carbon tape. The fixed biofilms were
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then coated with a layer of gold (7 nm thick) and examined
with an S-4300 scanning electron-microscope (Hitachi, Tokyo,
Japan) at 15 kV.
RT-PCR analysis
Total RNA was isolated from each isolate using an Invisorb
Spin Cell RNA Mini Kit (Invitek, Berlin, Germany). First-
strand cDNA was obtained using a reverse transcription
system (Gibco BRL) with 2 lg of total RNA, and the resulting
cDNA was then used as a template for PCR using primers
specific for the blaPER-1 gene (sense, 5¢-ATGAATG-
TCATTATAAAAGC; antisense, 5¢-AATTTGGGCTTAGGG-
CAAGAAA) and 16S rRNA (sense, 5¢-TGGCTCAGATT-
GAACGCTGGCGGC; antisense, 5¢-TACCTTGTTACGA
CTTCACCCCA). PCR amplification comprised 22 cycles of
94C for 60 s, 50C for 60 s and 72C for 60 s, after which the
amplified products were analysed by conventional agarose gel
electrophoresis. Band intensities of the PCR products were
measured using an image analysis program (MetaMorph;
Universal Imaging Corp., Downingtown, PA, USA), with data
expressed as ratios of each mRNA normalised to 16S rRNA
amplified from the same cDNA sample.
Statistical methods
The software package SPSS 12.0K for Windows (SPSS Inc.,
Chicago, IL, USA) was used for statistical analyses. Student’s
t-test and Wilcoxon’s rank sum test were used to compare
clinical isolates with or without blaPER-1. Correlations (cell
adherence and biofilm formation; blaPER-1 mRNA expression
level and cell adherence ⁄biofilm formation) were evaluated
using Pearson’s correlation coefficient and Spearman’s rank
correlation. Data were expressed as mean values ± SD, with
p <0.05 considered to be statistically significant.
RESULTS
In the cell adherence assay, the total number of
adhered bacteria ⁄ 100 cells ranged between
29 ± 8 and 2077 ± 890 for the 23 clinical isolates
of A. baumannii, and was 18 ± 5 for the type
strain ATCC 19606 (Table 1). Among the isolates
carrying blaPER-1, two (1169 and 1656-2) showed
c. 100-fold higher adherence than the
ATCC 19606 type strain. The other ten isolates
carrying blaPER-1 showed higher adherence
(97.5 ± 59) than the 11 isolates without blaPER-1
(45.6 ± 10; Student’s t-test, p <0.005).
In a polystyrene adherence test, all 23 A. bau-
mannii isolates and the A. baumannii type strain
(ATCC 19606) were able to attach to a polystyrene
disk, suggesting the presence of biofilm-forming
ability. In a subsequent biofilm formation assay in
microtitre plates, OD570 values (mean ± SD) for
the 23 A. baumannii MDR isolates ranged between
1.14 ± 0.42 and 3.98 ± 0.13, as compared with
0.64 ± 0.11 for the type strain (Fig. 1). As with the
cell adhesion assay, isolates carrying the blaPER-1
gene produced more biofilm than isolates without
blaPER-1. The mean OD570 value (2.4 ± 0.6) of the
12 isolates carrying blaPER-1 was significantly
higher than that of the 11 isolates without
blaPER-1 (1.6 ± 0.3; Student’s t-test, p <0.001; Wil-
coxon’s two-sample test, p <0.001).
Fig. 2 shows the level of expression of blaPER-1
in the isolates that carried this gene. The levels of
PER-1 mRNA were expressed as ratios of PER-1
mRNA normalised to 16S rRNA, with the rela-
tionships between the levels of PER-1 expression
and biofilm formation ⁄ cellular adhesiveness
being evaluated using Pearson’s correlation coef-
ficient. There were significant correlations
between the level of PER-1 expression and biofilm
formation (n = 12, r 0.89, p <0.001), and between
the level of PER-1 expression and cellular adhe-
siveness (n = 12, r 0.74, p 0.006).
The two isolates that showed the greatest
epithelial cell adhesiveness (isolates 1169 and
1656-2) also produced large amounts of biofilm,
suggesting a positive association between biofilm-
forming capacity and cell adhesiveness. When the
correlation coefficient between these two vari-
ables was calculated for all 24 isolates of A. bau-
mannii, there was a highly significant correlation
between biofilm-forming capacity and cell adhe-
siveness (n = 24, r 0.77, p <0.0001 with Pearson’s
correlation coefficient; n = 24, r 0.80, p <0.0001
with Spearman’s rank correlation).
Finally, biofilm formation by A. baumannii iso-
late 1656-2, which formed the highest amount of
biofilm, was markedly reduced (55–65%) in the
Table 1. Adherence of clinical isolates of Acinetobacter
baumannii to respiratory epithelial cellsa








ATCC 19606 Type strain 18 ± 5 335N6 Open pus 181 ± 64
5075 Blood 40 ± 5 667 Sputum 177 ± 55
1322 Sputum 29 ± 8 870 Pleural fluid 90 ± 20
375 Sputum 66 ± 15 1169 Sputum 1767 ± 550
502 Urine 44 ± 17 1656-2 Sputum 2077 ± 890
450 Urine 41 ± 12 1007 Sputum 99 ± 21
439 Urine 51 ± 18 489 Open pus 60 ± 15
671 Sputum 41 ± 10 690 Sputum 45 ± 11
263 Sputum 54 ± 19 287 Sputum 55 ± 14
298 Urine 55 ± 21 872 Open pus 178 ± 38
831 Urine 39 ± 14 726 Sputum 40 ± 15
913 Sputum 42 ± 16 609N6 Open pus 50 ± 17
aThe number of bacteria adherent to 100 NCI-H292 cells was determined. Each
experiment was performed in duplicate and repeated on three occasions. Data are
expressed as means ± SD.
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presence of EDTA. Subsequent analysis by scan-
ning electron-microscopy revealed a reduction in
the number of colonising bacterial cells and in the
amount of biofilm produced in the presence of
EDTA (Fig. 3).
DISCUSSION
A few previous reports have described the ability
of clinical isolates of A. baumannii to attach to and
form biofilms on glass surfaces [9,19,20]. Vidal
et al. [9] found that an A. baumannii isolate from a
respiratory tract infection formed biofilm on the
surface of coverslips, and that this comprised an
amorphous material similar to exopolysaccharide.
Tomaras et al. [19] demonstrated that A. bauman-
nii ATCC 19606 adhered to and formed biofilm
on plastic and glass surfaces, and that disruption
of the csuC and csuE open reading frames resulted
in non-piliated cells, and the abolishment of cell
attachment and biofilm formation. More recently,
Siroy et al. [20] demonstrated that a clinical MDR
isolate formed significant amounts of biofilm, and
that this correlated with the accumulation of
certain outer-membrane proteins, e.g., NlpE and
CsuD, that have been described previously as
being involved in bacterial adhesion. In E. coli,
NlpE is a sensing molecule that generates an
adhesion-specific signal to a two-component sys-
tem that is involved in surface sensing and
biofilm formation [21,22]. Overall, these previous
observations agree with the main finding in the
(a)
(b)
Fig. 1. Biofilm formation assay re-
sults for clinical isolates of Acineto-
bacter baumannii. (a) Biofilms stained
with gentian violet 0.1% v ⁄v for
15 min. (b) To measure the relative
amount of biofilm, the gentian vio-
let-stained biofilms were solubilised
with ethanol 95% v ⁄ v for 5 min, and
biofilm cell-associated dye was mea-
sured at OD570 using an ELISA
reader. Each experiment was per-
formed in triplicate and repeated on
three occasions. HB101 is the Escher-
ichia coli control strain; ATCC 19606



















































Fig. 2. Comparative RT-PCR analy-
sis of blaPER-1 gene expression by
clinical isolates of Acinetobacter bau-
mannii. (a) Agarose gel showing
representative RT-PCR results for
the blaPER-1 gene and 16S rRNA. (b)
The density of each band in each
lane was quantified by scanning
densitometry and then expressed
as means ± SD. Data are expressed
as ratios of PER-1 mRNA norma-
lised to 16S rRNA. M, DNA size
marker.
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present study that MDR clinical isolates of A. bau-
mannii have the ability to form large amounts of
biofilm, and that this ability shows a significant
correlation with epithelial cell adherence.
Acquisition of the ability to form biofilm could
be a good strategy to enhance a microorganism’s
survival under stressed conditions, e.g., during
host invasion or following antibiotic treatment.
This is because cells growing in biofilms are
highly resistant to the components of the human
immune system and to numerous types of anti-
microbial agent. In addition, the ability of bacte-
rial cells to transfer genes horizontally is
enhanced within biofilm communities, thereby
facilitating the spread of antibiotic resistance
[1,15]. Thus, A. baumannii strains capable of form-
ing biofilm might be selected under antibiotic
pressure, or conversely, A. baumannii might ac-
quire resistance to multiple drugs within biofilm
communities. In either event, the high colonising
capacity of A. baumannii, combined with its resis-
tance to multiple drugs, will contribute to the
organism’s survival and further dissemination in
the hospital setting.
An interesting finding of the current study was
that A. baumannii isolates carrying blaPER-1 showed
a significantly higher capacity for epithelial cell
adherence and biofilm formation when compared
with A. baumannii isolates without blaPER-1.
Although the 12 isolates carrying the blaPER-1 gene
were clonally related [16], the levels of expression
of blaPER-1 varied among these isolates, and
showed a significant correlation with the capacity
of each isolate to form biofilm and to adhere to
epithelial cells. Similarly, Sechi et al. [23] showed
that PER-1 production in A. baumanniiwas related
to cell adhesion. Vahaboglu et al. [7] found that
PER-1 production was an independent indicator
of poor prognosis in a cohort study that compared
the clinical outcomes of patients in an intensive
care unit who were infected with Acinetobacter
strains resistant to third-generation cephalospo-
rins. Cells growing in biofilms are known to be
highly resistant to components of the human
immune system and to numerous types of anti-
microbial agents. The high capacity for biofilm
formation shown by A. baumannii isolates carry-
ing blaPER-1 could therefore be a possible explana-
tion for the findings of Vahaboglu et al. [7].
Further studies should focus on the clinical out-
comes of patients infected with PER-1-producing
A. baumannii strains with a high capacity for
biofilm formation.
The metal chelator EDTA is known to have
activity against biofilms associated with bacteria
such as Staphylococcus spp., Candida spp. and
Pseudomonas aeruginosa [24–26]. Raad et al. [25]
showed that a flush solution consisting of mino-
cycline–EDTA was highly efficacious in prevent-
ing catheter-related colonisation, bacteraemia and
endocarditis in rabbits, and that this flush
solution was also highly effective in reducing
colonisation with Staphylococcus epidermidis,
Staphylococcus aureus and Candida albicans cells
embedded in fresh and mature biofilm adhering
to catheter surfaces [26]. In the present study,
treatment with EDTA caused a 55–65% reduction
in biofilm formation. This inhibitory effect was
not observed following treatment with trypsin
(data not shown), and it was therefore concluded
that the major constituent of biofilms formed by
A. baumannii is polysaccharide. A reduction in the
number of colonising bacterial cells, as well as
biofilm formation, in the presence of EDTA was
revealed by scanning electron-microscopy. EDTA
had no effect on the planktonic growth of bacteria
(data not shown), so the reduction in the number
of colonising bacterial cells in the presence of
EDTA seems to be a result of the detachment
of biofilm cells, as opposed to the inhibition of
(a)
(b)
Fig. 3. Inhibition of biofilm forma-
tion by EDTA in a clinical strain of
Acinetobacter baumannii. The mor-
phology of biofilms formed by
A. baumannii strain 1656-2 in (a) the
absence or (b) the presence of EDTA
was viewed under a scanning elec-
tron-microscope at ·5000, ·10 000,
·20 000 and ·25 000 magnification.
The scale magnification bar indi-
cates 2 lm.
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bacterial growth. The efficient reduction in bio-
film formation by A. baumannii in the presence of
EDTA suggested that the flushing strategy em-
ployed in previous studies [24–26] could also be
applicable for A. baumannii.
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